¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"late mRNA"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • late
    ¸¸±â-, Èıâ-
  • late asthmatic response
    ¸¸±âõ½Ä¹ÝÀÀ, Èıâõ½Ä¹ÝÀÀ
  • late dumping syndrome
    ¸¸±â´ýÇÎÁõÈıº
  • late effect
    ¸¸±âÈ¿°ú
  • late labor
    Èıâ»êÅë, ¸¸±âÁøÅë
  • late postpartum hemorrhage
    ¸¸±âºÐ¸¸ÈÄÃâÇ÷
  • late relapse
    ¸¸±âÀç¹ß, ´ÊÀºÀç¹ß
  • late systolic murmur
    ¼öÃ฻±âÀâÀ½
  • late-onset depression
    Èıâ¹ßº´¿ì¿ïÁõ
  • late-onset schizophrenia
    Èıâ¹ßº´Á¤½ÅºÐ¿­º´
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • late deceleration
    ´ÊÀº½ÉÀå¹Úµ¿°¨¼Ò
  • severe late deceleration
    ½ÉÇÑ´ÊÀº½ÉÀå¹Úµ¿°¨¼Ò
  • late postpartum hemorrhage
    ¸¸±âºÐ¸¸ÈÄÃâÇ÷
  • late reaction
    (¢¡delayed reaction) Áö¿¬¹ÝÀÀ
  • late asthmatic response
    ¸¸±âõ½Ä¹ÝÀÀ, Èıâõ½Ä¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • late-onset depression
    Èıâ¹ßº´¿ì¿ïÁõ
  • late effect
    ¸¸±âÈ¿°ú, ÈÄÀ¯È¿°ú
  • late
    ¸¸±â-, Èıâ-
  • late labor
    Èıâ»êÅë
  • late reaction
    (¢¡delayed reaction) Áö¿¬¹ÝÀÀ
  • late relapse
    ¸¸±âÀç¹ß, ´ÊÀºÀç¹ß
  • late systolic murmur
    ¼öÃ฻±âÀâÀ½
  • late-onset schizophrenia
    Èıâ¹ßº´Á¤½ÅºÐ¿­º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acute and late normal tissue effects
    Á¤»óÁ¶Á÷ ±Þ¼º¿µÇâ, Á¤»óÁ¶Á÷ ¸¸¼º ¿µÇâ
  • polygenic mRNA
    ´ÙÀ¯ÀüÀÚ mRNA
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • early mRNA
    ÃʱâÃâÇö mRNA
  • polygenic mRNA
    ´ÙÀ¯ÀüÀÚ mRNA
  • acute and late normal tissue effects
    Á¤»óÁ¶Á÷ ±Þ¼º¿µÇâ, Á¤»óÁ¶Á÷ ¸¸¼º ¿µÇâ
  • late
    ¸¸±â(Ø´Ñ¢)ÀÇ, ÈĹß(ý­Û¡)ÀÇ, ÈÄÀ¯(ý­ë¶)ÀÇ.
  • late aneurysm
    ¸¸¹ß¼º µ¿¸Æ·ù(Ø´Û¡àõ ÔÑØæ×»).
  • late complication
    ¸¸±âÀåÇØ
  • late effect
    ÈÄÀ¯È¿°ú(ý­ë¶üùÍý).
  • late effect
    ¸¸±âÈ¿°ú
  • late fetal death
    ¸¸±âžƻç¸Á(Ø´Ñ¢÷Ãä®ÞÝØÌ).
  • late gestation
    ÀÓ½ÅÈıâ(ìôããý­Ñ¢).
  • late gestational toxicosis
    ¸¸±âÀÓ½ÅÁßµ¶(Áõ)(Ø´Ñ¢ìôããñéÔ¸ñø).
  • late labor
    ¸¸±âÁøÅë(Ø´Ñ¢òç÷Ô).ÈıâºÐ¸¸
  • late period of limb buds
    ÆÈ´Ù¸®½ÏÈıâ
  • late postprandial postgastrectomy syndrome
    Èıâ½ÄÈļº À§ÀýÁ¦ÈÄÁõÈıº(ý­Ñ¢ãÝý­àõêÖôîð¶ý­ñøý¦ÏØ).
  • late reaction
    Áö¿¬¹ÝÀÀ.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Late period of limb buds
    ÆÈ´Ù¸®½ÏÈıâ
    [¿¾ ¿ë¾î] Áö·ÚÈıâ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • late mRNA
    ¸¸±â(عѢ) mRNA
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • late enzyme
    ¸¸±âÈ¿¼Ò(عѢý£áÈ)
  • late gene
    ¸¸±âÀ¯ÀüÀÚ(عѢë¶îîí­)
  • late protein
    ¸¸±â´Ü¹éÁú(عѢӱÛÜòõ)
  • masked mRNA
    ÀºÆó(ëßøÌ) mRNA
  • mRNA
    (å²) messenger RNA
  • mRNA coding triplet
    mRNA ÄÚµå»ïÁßÇ×(ß²ñìú£)
  • mRNA strand
    mRNA°¡´Ú
  • mt mRNA
    (å²) mitochondrial mRNA
  • pre-mRNA
    Àü±¸(îñÏÌ) mRNA
  • storage mRNA
    ÀúÀå(îÍíú) mRNA
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • late
    ¸¸±âÀÇ, ÈĹßÀÇ, ÈÄÀ¯ÀÇ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LA lactic acid; large amount; laser angioplasty; late abortion; late antigen; latex agglutination; left...
LAR laryngology; late asthmatic response; late reaction; left arm recumbent; leukocyte antigen-related
mRNA messenger Ribo-Nucleic Acid
H-mRNA H-chain messenger ribonucleic acid
mRNA messenger ribonucleic acid
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
pre-mRNA Precursor mRNA
mRNA E-messenger RNA
mRNA Messenger ribonucleic acid
NMD Nonsense-mediated mRNA decay
mRNA RNA
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute and late normal tissue effects£¨Á¤»ó Á¶Á÷ ±Þ¼º ¿µÇ⣩

    acute angle

    ¿¹°¢
    Á÷°¢º¸´Ù ÀÛÀº °¢.
  • late closing click
    Æó±¸ ¸»±â Ŭ¸¯À½
    ÇÏ¾Ç °úµÎÀÇ ÈĹæ ȰÁÖ ¿îµ¿ÀÌ ³¡³ª±â ¹Ù·Î Á÷Àü¿¡ °üÀý¿¡¼­ »ý±â´Â ¼Ò¸®.
  • late complication
    ¸¸¼º Àå¾Ö
    ¹æ»ç¼±À» ¹Þ¾ÒÀ» ¶§ÀÇ ÀÎü¿¡ ³ªÅ¸³ª´Â Á÷Á¢Àû, °£Á¢Àû Àå¾Ö·Î¼­ ½Ä¿å ºÎÁø, µÎÅë, ±¸Åä, ÃâÇ÷, ºóÇ÷, ºÒÀÓ µîÀÌ ÀÖ´Ù.
  • late cortical cerebelar atrophy
    ¸¸¹ß¼º ÇǺμº ¼Ò³ú À§ÃàÁõ
  • late effet
    ÈÄÀ¯ È¿°ú
    ¾î¶² ¾à¹°À» »ç¿ëÇßÀ» ¶§ ½ÇÁ¦ ±× ¾à¹°ÀÇ È¿°ú´Â ¾Æ´ÏÁö¸¸ µû¶ó¼­ ¹ß»ýÇÏ´Â ¾ç¼º Áõ»ó.
  • late eruption
    ¸ÍÃâ Áö¿¬, ¸¸±â»ýÄ¡
    Ä¡¾ÆÀÇ ¸ÍÃâ±â°¡ Àü¸éÀûÀ¸·Î ¶Ç´Â ÀϺΠ´Ê¾îÁö´Â °ÍÀ» ¸»ÇÑ´Ù. ¿øÀÎÀ¸·Î¼­´Â Ä¡°üÀÇ ÀÌ»óÀ¸·Î Ä¿´Ù¶õ Ä¡¾Æ, ¸ÍÃâºÎÀÇ Çù¼Ò, Ä¡¹èÀÇ ÀüÀ§, Ä¡¾ÆÁ¾À̳ª ³¶Æ÷ µîÀÌ ÀÖ´Ù.
  • late generalization
    ¸¸±â ¸¸¿¬
    °áÇÙÀÌ Àü½ÅÀ¸·Î È®»êµÇ¾î À²¸³ °áÇÙÀ¸·Î ¹ßÀüÇÏ´Â ÇÑ °¡ÁöÇüÀ¸·Î óÀ½ °¨¿°µÈ ºÎÀ§°¡ ÈÞÁöÇϰí Àå±â °áÇÙÁõÀÌ µÈ ÈÄ ±× º´¼Ò¸¦ Ãâ¹ßÁ¡À¸·Î Ç÷Ç༺À¸·Î È®ÀåµÇ´Â °ÍÀÌ´Ù.
  • late luteal phase dysphoric disorder
    ¸»±â Ȳü±â ºÒÄè Àå¾Ö
  • late middle age
    Àå³â±â
    40´ë ÈĹݿ¡¼­ 50´ë ÈĹݱîÁöÀÇ ³ªÀÌ.
  • late opening click
    °³±¸ ¸»±â Ŭ¸¯À½
    ÇÏ¾Ç °úµÎÀÇ Àü¹æ ȰÁÖ ¿îµ¿ÀÌ ³¡³ª±â ¹Ù·Î Á÷Àü¿¡ °üÀý¿¡¼­ »ý±â´Â ¼Ò¸®.
  • late postprandial hypoglycemia
    ½ÄÈÄ Èıâ ÀúÇ÷´çÁõ
    À§ ÀýÁ¦ ÈÄ º¸°Ô µÇ´Â Èı⠴ýÇÎ Áõ»óÀÇ Çϳª.
  • late reaction
    Áö¿¬ ¹ÝÀÀ
  • late schizophrenia
    ¸¸¹ß ºÐ¿­Áõ
    40¼¼ ÀÌÈÄ¿¡ ÃʹßÇÏ´Â Á¤½ÅºÐ¿­Áõ. ¿©¼º¿¡°Ô ¸¹À¸¸ç ¿¹ÈÄ´Â ÀϹÝÀûÀ¸·Î ¾çÈ£Çϰí ÁßÁõÀÇ °áÇÔÀ» ³²±â´Â °æ¿ì´Â Àû´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
alternative mRNA splicing Splicing different exons in or out of messenger RNA to form different mRNA transcripts.
(09 Oct 1997)
capping of mRNA The process of adding a guanosine nucleotide to the 5'-end (the beginning) of an eukaryotic mRNA, then methylating (adding a -CH3 to) the guanosine.
(09 Oct 1997)
maternal mRNA <molecular biology> Messenger RNA found in oocytes and early embryos that is derived from the maternal genome during oogenesis.
See: masked messenger RNA.
(18 Nov 1997)
mRNA <molecular biology> Single stranded RNA molecule that specifies the amino acid sequence of one or more polypeptide chains. This information is translated during protein synthesis when ribosomes bind to the mRNA.
In prokaryotes, mRNA is normally formed by splicing a large primary transcript from a DNA sequence and protein synthesis starts while the mRNA is still being synthesised. Prokaryote mRNAs are usually very short lived (average t 1/2 is 5mins.).
In contrast, in eukaryotes the primary transcripts (HnRNA) are synthesised in the nucleus and they are extensively processed to give the mRNA that is exported to the cytoplasm where protein synthesis takes place.
This processing includes the addition of a 5' 5' linked 7 methyl guanylate cap at the 5' end and a sequence of adenylate groups at the 3' end, the poly A tail, as well as the removal of any introns and the splicing together of exons, only 10% of HnRNA leaves the nucleus.
Eukaryote mRNAs are comparatively long lived with a half life ranging from 30minutes to 24 hours.
(27 Jun 1999)
mRNA (2'-O-methyladenosine-N6-)-methyltransferase <enzyme> Involved in capping mRNA
Registry number: EC 2.1.1.62
Synonym: mRNA n(6)-adenosine methyltransferase, mra methyltransferase, RNA(2'-o-methyladenosine-n(6)-)methyltransferase
(26 Jun 1999)
mRNA(adenine-N6)-methyltransferase <enzyme> Methylates mRNA at internal adenosine within the consensus sequence puac(a/c/u)
Registry number: EC 2.1.1.-
Synonym: mRNA-a-n6-methyltransferase, mRNA(adenine-n6)-methylase
(26 Jun 1999)
mRNA (guanine(N7))-methyltransferase <enzyme> Catalyses s-adenosyl-l-methionine and g(5')pppr-RNA to yield s-adenosyl-l-homocysteine and m(7)g(5')pppr-RNA; mRNA containing an n(7)-methylguanine cap
Registry number: EC 2.1.1.56
Synonym: mRNA (guanine-7-)methyltransferase, mRNA(guanine-7-)methyltransferase, RNA (guanine-7) methyltransferase, abd1 gene product
(26 Jun 1999)
mRNA guanylyltransferase <enzyme> Catalyses transfer of GMP residue from GTP to 5' end of RNA to form cap structure identified as g(5')pppn; can also modify synthetic poly(a) and poly(g) to form m7g(5')pppan and m7g(5')pppgn; see also capping enzyme, vaccinia virus
Registry number: EC 2.7.7.50
Synonym: RNA guanylyltransferase, m-RNA guanylyltransferase, GTP mRNA guanylyltransferase, mRNA capping enzyme, mRNA 5'-guanylyltransferase, cgt1 gene product, ceg1 gene product
(26 Jun 1999)
mRNA maturase <enzyme> Also potent endonuclease involved in recombination
Registry number: EC 2.7.7.-
Synonym: RNA, mitochondrial maturase, RNA maturase
(26 Jun 1999)
mRNA (nucleoside-O(2'))-methyltransferase <enzyme> Catalyses the reaction of s-adenosyl-l-methionine and m(7)g(5')pppr-RNA to yield s-adenosyl-l-homocysteine and m(7)g(5')ppprm-RNA; mRNA containing an o(2')-methylpurine cap
Registry number: EC 2.1.1.57
(26 Jun 1999)
polycistronic mRNA <molecular biology> A single mRNA molecule that is the product of the transcription of several tandemly arranged genes, typically the mRNA transcribed from an operon.
(18 Nov 1997)
6-methyladenine mRNA methyltransferase <enzyme> Forms internal n6-methyladenine residues
Registry number: EC 2.1.1.-
Synonym: m6a mRNA methyltransferase
(26 Jun 1999)
receptors, very late antigen Members of the integrin family appearing late after T-cell activation. They are a family of proteins initially identified at the surface of stimulated T-cells, but now identified on a variety of cell types. At least six vla antigens have been identified as heterodimeric adhesion receptors consisting of a single common beta-subunit and different alpha-subunits.
(12 Dec 1998)
late apical systolic murmur A murmur previously considered benign, or even extracardiac, with a possible relationship to pericardial disease; it often represents mitral insufficiency, often localised and of moderate severity but with propensity for developing bacterial endocarditis, and is frequently associated with systolic click and mitral prolapse (Barlow syndrome; a balloon or billowing mitral valve leaflet) often producing a click, murmur, or both, as it prolapses during systole into the left atrium.
(05 Mar 2000)
late benign syphilis Late syphilis, manifested by serologic evidence of infection, but without any clinical manifestations.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • late
    ´ÊÀº,ÃÖ±ÙÀÇ,¾ÕÀÇ,´Ê°Ô
  • late on
    ³ªÁß¿¡
  • of late
    ¿äÁîÀ½
  • late
    ´ÊÀº;´õµò;¿äÀüÀÇ;Áö³­¹øÀÇ;ÀÛ°íÇÑ;°í;keep ~ hours ¹ã ´Ê°Ô ÀÚ°í ¾ÆÄ§ ´Ê°Ô ÀϾ´Ù;of ~ (years) ¿äÁîÀ½;±Ù³â
  • late
    ´Ê°Ô;µÚ´Ê°Ô;Àú¹°¾î;¹ã´Êµµ·Ï;ÃÖ±Ù;Better ~ than never;´ÊÀ»¸ÁÁ¤ ¾È ÇÏ´À´Ïº¸´Ù ³´´Ù;early and ~ ¾ÆÄ§ºÎÅÍ ¹ã°¡Áö
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á